DHSC (UK) · Jun 4, 2026
Lord Mann's recommendations to tackle antisemitism accepted
Government to act on Lord Mann’s report about tackling racism and antisemitism in the NHS.
Latest medical news · page 43
The latest headlines across every section, pulled from official and open-access sources.
DHSC (UK) · Jun 4, 2026
Official Statistics: Adult social care provider statistics, England: quarterly update to May 2026
Official statistics on the number of people receiving adult social care services, and information on adult social care settings.
DHSC (UK) · Jun 4, 2026
Guidance: Adult social care provider statistics, England: background quality and methodology
How the Department of Health and Social Care (DHSC) puts together the statistics in its quarterly reports.
FDA MedWatch · Jun 4, 2026
Early Alert: Insulin Pump Issue from Insulet
Certain Omnipod Pods may have a tear in the tubing that allows insulin to leak outside the Pod instead of being delivered to the body.
CDC Emerging Infections · Jun 4, 2026
National Surveillance of Enterovirus D68 Upsurge, France, 2024
M. Jeannoël et al.
CDC Travel Notices · Jun 4, 2026
Level 1 - Hepatitis A in Canada
Manitoba, Canada is currently experiencing a hepatitis A virus (HAV) outbreak. HAV is contagious and spreads through close person-to-person contact and by eating contaminated food or drink.
CDC Travel Notices · Jun 4, 2026
Level 2 - Chikungunya in French Guiana
There is an outbreak of chikungunya in French Guiana. You can protect yourself by preventing mosquito bites.
JAMA Network Open · Jun 4, 2026
Online Menopause Information Search Patterns and Commercial Content
This cohort study evaluates 20-year trends to quantify changes in menopause-related online searches compared with other health domains.
JAMA Network Open · Jun 4, 2026
Federal Lobbyist Spending to Influence 340B Drug Pricing Program Policy
This cross-sectional study identifies organizations engaged in lobbying related to the 340B Drug Pricing Program, estimates their lobbying expenditures, and characterizes their policy priorities.
JAMA Network Open · Jun 4, 2026
Aspirin Use for Secondary Prevention of CVD Amid Negative Messaging
This cross-sectional study assesses whether aspirin use for secondary prevention changed from 2015 to 2020 and investigates the factors associated with stopping therapy among adults with atherosclerotic cardiovascular disease.
JAMA Network Open · Jun 4, 2026
Health Care Cost Trajectories in the Last Year of Life by Age at Death
This cohort study compares total and out-of-pocket health care costs in the last year of life for US decedents aged 0 to 64 years vs 65 years or older, with and without standardization to Medicare pricing.
JAMA Network Open · Jun 4, 2026
Supply Chain Events and Risk of Drug Shortage in Canada
This cohort study quantifies incident drug shortages following supply chain events in Canada and examines drug characteristics associated with increased shortage risk.
JAMA Network Open · Jun 4, 2026
Changes in Maternal Care and Infant Health After Noneconomic Damage Cap Repeals
This cross-sectional study examines whether repealing noneconomic damage caps for awards in medical malpractice cases is associated with changes in maternal care and infant health outcomes.
JAMA Network Open · Jun 4, 2026
Federal Policy Changes and DEI Content in US Medical Education
This cohort study of US medical school websites examines the removal or alteration of language about diversity, equity, and inclusion at 3 time points in 2025 following legal, political, and regulatory pressures.
JAMA Network Open · Jun 4, 2026
Investments in Childhood Community Resources and Subsequent Adult Health Outcomes
This cohort study investigates whether childhood exposure to public spending on community resources is associated with subsequent adult health.
MedCity News · Jun 3, 2026
Former FDA Officials: There’s Opportunity to Rebuild the Agency — But Not the Way It Was
Rick Pazdur, formerly the FDA’s top oncology official, said the FDA is at a critical juncture that could determine the direction of the world’s top regulator of medicines. Pazdur spoke during a STAT panel discussion during the annual meeting of the American Society of Clinical Oncology. The post Former FDA Officials: There’s Opportunity to Rebuild the Agency — But Not the Way It Was appeared first on MedCity News .
NHS England · Jun 3, 2026
NHS rolls out life-extending drug for hundreds of women with ovarian cancer
Hundreds of women with hard-to-treat ovarian cancer could benefit from a new, life-extending drug on the NHS from today – the first new addition to NHS treatment in over 20 years. The new targeted therapy – mirvetuximab soravtansine – will be offered to patients living with ovarian cancer whose disease has stopped responding to standard […]
WHO · Jun 3, 2026
Unsafe food causes 866 million illnesses and 1.5 million deaths annually, young children at highest risk
Children aged less than five years face almost three times the risk of illness from unsafe food than older children and adults, according to new estimates released today by the World Health Organization (WHO).
MedCity News · Jun 3, 2026
Peterson Philanthropies Unveils Employer Health Analytics Company via $50M Commitment
Peterson Philanthropies launched Peterson Health Analytics with a $50 million commitment to help employers better understand and manage healthcare costs. The post Peterson Philanthropies Unveils Employer Health Analytics Company via $50M Commitment appeared first on MedCity News .
MedTech Dive · Jun 3, 2026
Edwards gets FDA approval for surgical tricuspid valve
Built specifically to mimic the native tricuspid anatomy, the implant is intended to address an unmet patient need.
ACP · Jun 3, 2026
Many adults with a normal BMI may still have obesity-related health risks
These findings highlight the potential importance of identifying abnormal anthropometric characteristics in clinical settings to better capture individuals at risk for obesity-related health complications.
MedCity News · Jun 3, 2026
What Will the Next Healthcare Exit Winners Look Like?
Healthcare startup exits are improving but remain highly selective. Jack Euston, general partner Fountain Health Partners, expects the next exit cycle to reward AI-enabled, workflow-embedded companies while sidelining undifferentiated point solutions and growth-at-all-costs models. The post What Will the Next Healthcare Exit Winners Look Like? appeared first on MedCity News .
ADA (Diabetes) · Jun 3, 2026
Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity
Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity mcarmody Wed, 06/03/2026 - 16:49 Press release Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity NEW ORLEANS, La. June 6, 2026 Findings highlight use of once-weekly injection to expand potential options for weight reduction, A1C control, knee osteoarthritis, and obstructive sleep apnea First-ever type 2 diabetes and obesity phase 3 study results for retatrutide, a novel glucose-dependent insulinotropic…
MedTech Dive · Jun 3, 2026
Medtronic boosts revenue by nearly double digits in Q4
Strength in cardiac ablation solutions, where the company picked up market share, helped Medtronic post its best annual revenue growth rate in a decade.